You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ISV-303

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle, Xibrom™)

Completed
Has Results
  • Ocular Inflammation
  • ISV-303
  • +2 more
  • (no location specified)
Nov 18, 2021

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

Completed
Has Results
  • Ocular Inflammation
  • ISV-303
  • DuraSite Vehicle
  • (no location specified)
Nov 18, 2021

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

Completed
Has Results
  • Ocular Inflammation
  • ISV-303
  • DuraSite Vehicle
  • (no location specified)
Nov 18, 2021

Cataract Trial (ISV-303, Bromday™)

Completed
Has Results
  • Cataract
  • (no location specified)
Nov 18, 2021

Crohn's Disease, IBD Trial in Worldwide (Brazikumab Induction Dose, Brazikumab Maintenance Dose)

Enrolling by invitation
  • Crohn's Disease
  • IBD
  • Brazikumab Induction Dose
  • Brazikumab Maintenance Dose
  • Lincoln, California
  • +116 more
Jan 12, 2023

Healthy Male Subjects Trial in Tokyo (TAS-303, [14C]TAS-303)

Active, not recruiting
  • Healthy Male Subjects
  • TAS-303, [14C]TAS-303
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Nov 17, 2022

Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)

Active, not recruiting
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS
  • Gilbert, Arizona
  • +123 more
Nov 21, 2022

MDD Trial (NMRA-335140)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 1, 2023

Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia Trial (povetacicept)

Not yet recruiting
  • Immune Thrombocytopenia
  • +3 more
  • (no location specified)
Mar 9, 2023

Chronic Migraine Trial in Beijing, Taiyuan, Hangzhou (Atogepant)

Completed
  • Chronic Migraine
  • Beijing, Beijing, China
  • +2 more
Dec 21, 2022

Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • (no location specified)
Feb 16, 2023

Stress Urinary Incontinence Trial in Japan (TAS-303 18 mg/day, Placebo)

Completed
  • Stress Urinary Incontinence
  • TAS-303 18 mg/day
  • Placebo
  • Aichi, Japan
  • +3 more
Feb 8, 2022

Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,

Completed
  • Cervical Dysplasia
  • +2 more
  • VGX-3100
  • +2 more
  • Tucson, Arizona
  • +52 more
Oct 13, 2022

Active, Symptomatic Blepharitis Trial in Newport Beach (ISV-305, Vehicle)

Completed
Has Results
  • Active, Symptomatic Blepharitis
  • Newport Beach, California
    Clinical Research Center
Nov 18, 2021

Blepharitis Trial in United States (ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined), Azasite, Dexamethasone)

Completed
  • Blepharitis
  • ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
  • +3 more
  • Chandler, Arizona
  • +44 more
Nov 18, 2021

Dry Eye Disease Trial (ISV 101)

Withdrawn
  • Dry Eye Disease
  • ISV 101
  • (no location specified)
Nov 18, 2021

Inflammation and Pain Associated With Cataract Surgery Trial in Austin (ISV-305, Vehicle)

Completed
Has Results
  • Inflammation and Pain Associated With Cataract Surgery
  • Austin, Texas
    Clinical Research Center
Nov 18, 2021

Inflammation and Pain Associated With Cataract Surgery Trial in Memphis (ISV-305, Vehicle)

Completed
Has Results
  • Inflammation and Pain Associated With Cataract Surgery
  • Memphis, Tennessee
    Clinical Research Center
Nov 18, 2021

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • (no location specified)
Feb 15, 2022

Lennox Gastaut Syndrome Trial in Kielce, Poznan (Rufinamide)

Available
  • Lennox Gastaut Syndrome
  • Kielce, Poland
  • +1 more
Apr 4, 2022

Angioedema Trial in United States (Lanadelumab)

Recruiting
  • Angioedema
  • Birmingham, Alabama
  • +7 more
Mar 30, 2022

Pulmonary Arterial Hypertension Trial in Worldwide (Macitentan)

Completed
Has Results
  • Pulmonary Arterial Hypertension
  • Birmingham, Alabama
  • +157 more
Jan 19, 2022

Healthy Volunteers Trial in Brisbane, Melbourne (ALPN-303, Placebo)

Recruiting
  • Healthy Volunteers
  • Brisbane, Queensland, Australia
  • +1 more
Mar 31, 2022

Systemic Lupus Erythematosus Trial in Germany (Treat-to-target as a new treatment concept)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Treat-to-target as a new treatment concept
  • Freiburg, Baden Wurttemberg, Germany
  • +13 more
Jan 25, 2023

Rapid Mood Screener in Adult Unipolar Major Depressive Disorder

Not yet recruiting
  • Bipolar I Disorder
    • (no location specified)
    Jul 14, 2023